受试者-话题@MedSci

#受试者#

68篇内容 | 2568人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1446122, encodeId=70b9144612269, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=药物临床试验受试者隐私保护的有关伦理问题及其研究进展, objectType=article, longId=202610, objectId=1408202610ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1408202610ce, replyNumber=0, likeNumber=95, createdTime=2020-10-31, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1408202610ce, moduleTitle=药物临床试验受试者隐私保护的有关伦理问题及其研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1408202610ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446121, encodeId=00f41446121a4, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=“说谎”的临床研究受试者, objectType=article, longId=198868, objectId=d43219886852, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d43219886852, replyNumber=0, likeNumber=76, createdTime=2020-08-08, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d43219886852, moduleTitle=“说谎”的临床研究受试者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d43219886852)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446120, encodeId=b995144612094, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=CLIN CHEM LAB MED：中国健康受试者13个血液学参数的长期生物学变异？, objectType=article, longId=198766, objectId=cd9c198e66b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd9c198e66b1, replyNumber=0, likeNumber=91, createdTime=2020-08-07, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd9c198e66b1, moduleTitle=CLIN CHEM LAB MED：中国健康受试者13个血液学参数的长期生物学变异？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd9c198e66b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446119, encodeId=dd92144611942, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=阿斯利康/牛津大学的COVID-19疫苗反应强烈：100%的受试者体内抗体具有中和活性, objectType=article, longId=197886, objectId=e48819e8868b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e48819e8868b, replyNumber=0, likeNumber=68, createdTime=2020-07-23, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e48819e8868b, moduleTitle=阿斯利康/牛津大学的COVID-19疫苗反应强烈：100%的受试者体内抗体具有中和活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e48819e8868b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446118, encodeId=b381144611826, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=NEJM：美国最早启动的新冠疫苗使受试者均产生抗体，预防效果要观后效, objectType=article, longId=197625, objectId=107819e625c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=107819e625c7, replyNumber=0, likeNumber=54, createdTime=2020-07-18, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=107819e625c7, moduleTitle=NEJM：美国最早启动的新冠疫苗使受试者均产生抗体，预防效果要观后效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=107819e625c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446117, encodeId=34df144611e67, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=NEJM：Moderna的COVID-19候选疫苗在所有受试者中诱导了强烈的免疫应答, objectType=article, longId=197569, objectId=a86319e569b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a86319e569b8, replyNumber=0, likeNumber=91, createdTime=2020-07-17, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a86319e569b8, moduleTitle=NEJM：Moderna的COVID-19候选疫苗在所有受试者中诱导了强烈的免疫应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a86319e569b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446116, encodeId=1515144611635, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=GUT：地中海饮食降低超重和肥胖受试者的血浆胆固醇并改善肠道微生物组成, objectType=article, longId=196945, objectId=a9ec1969453b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9ec1969453b, replyNumber=0, likeNumber=0, createdTime=2020-07-04, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9ec1969453b, moduleTitle=GUT：地中海饮食降低超重和肥胖受试者的血浆胆固醇并改善肠道微生物组成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9ec1969453b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446115, encodeId=c9d6144611519, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=J Clin Periodontol:自我菌斑控制频率对有牙周炎病史的受试者牙龈健康的影响, objectType=article, longId=196501, objectId=4f981965019a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f981965019a, replyNumber=0, likeNumber=77, createdTime=2020-06-27, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f981965019a, moduleTitle=J Clin Periodontol:自我菌斑控制频率对有牙周炎病史的受试者牙龈健康的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f981965019a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446114, encodeId=10f1144611488, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=重磅！抗体阳转率100%！全球新冠灭活疫苗所有受试者全部产生抗体, objectType=article, longId=196012, objectId=fbd7196012cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbd7196012cd, replyNumber=0, likeNumber=75, createdTime=2020-06-18, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbd7196012cd, moduleTitle=重磅！抗体阳转率100%！全球新冠灭活疫苗所有受试者全部产生抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbd7196012cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446113, encodeId=70e11446113bb, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=新冠肺炎治疗性抗体进入临床试验，全球首例受试者已给药完成, objectType=article, longId=195567, objectId=646519556efb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=646519556efb, replyNumber=0, likeNumber=70, createdTime=2020-06-11, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=646519556efb, moduleTitle=新冠肺炎治疗性抗体进入临床试验，全球首例受试者已给药完成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=646519556efb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446112, encodeId=c1bc1446112d8, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=新版GCP第三十九条解读——受试者、研究者和医疗机构的补偿和保险, objectType=article, longId=194512, objectId=8b96194512cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b96194512cc, replyNumber=0, likeNumber=73, createdTime=2020-05-23, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b96194512cc, moduleTitle=新版GCP第三十九条解读——受试者、研究者和医疗机构的补偿和保险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b96194512cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446111, encodeId=dc781446111a4, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=赛诺菲拟招募数千受试者开展新冠疫苗试验，已在多国讨论购买, objectType=article, longId=193593, objectId=fec8193593de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fec8193593de, replyNumber=0, likeNumber=63, createdTime=2020-05-08, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fec8193593de, moduleTitle=赛诺菲拟招募数千受试者开展新冠疫苗试验，已在多国讨论购买, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fec8193593de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446110, encodeId=bb361446110ce, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=J Allergy Clin Immunol：天然花粉接触下过敏和不过敏受试者症状预测生物标记的确定 , objectType=article, longId=192825, objectId=4f4d192825d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f4d192825d2, replyNumber=0, likeNumber=90, createdTime=2020-04-24, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f4d192825d2, moduleTitle=J Allergy Clin Immunol：天然花粉接触下过敏和不过敏受试者症状预测生物标记的确定 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f4d192825d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446109, encodeId=e7d414461097c, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=深度：新药受试者招募的喜与忧, objectType=article, longId=192172, objectId=7f561921e231, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f561921e231, replyNumber=0, likeNumber=86, createdTime=2020-04-14, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f561921e231, moduleTitle=深度：新药受试者招募的喜与忧, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f561921e231)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446108, encodeId=8e4914461084c, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=J Dent Res：牙龈免疫细胞功能的根本性差异可能导致了T2D受试者PD的风险和严重程度的增加, objectType=article, longId=191809, objectId=d6811918091f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6811918091f, replyNumber=0, likeNumber=85, createdTime=2020-04-10, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6811918091f, moduleTitle=J Dent Res：牙龈免疫细胞功能的根本性差异可能导致了T2D受试者PD的风险和严重程度的增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6811918091f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446107, encodeId=f1af144610ebb, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=【研究】在研疫苗对健康受试者到底有多大风险？, objectType=article, longId=191091, objectId=35a91910917b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35a91910917b, replyNumber=0, likeNumber=72, createdTime=2020-04-01, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35a91910917b, moduleTitle=【研究】在研疫苗对健康受试者到底有多大风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35a91910917b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446106, encodeId=afd7144610617, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=Front Pharmacol：常规抗骨质疏松药物治疗是否可以降低男性受试者发生骨折的风险, objectType=article, longId=189388, objectId=d0ef189388b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0ef189388b4, replyNumber=0, likeNumber=58, createdTime=2020-03-06, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0ef189388b4, moduleTitle=Front Pharmacol：常规抗骨质疏松药物治疗是否可以降低男性受试者发生骨折的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0ef189388b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446105, encodeId=a53e14461056a, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=GUT：粪便免疫化学结果阴性的受试者中的粪便血红蛋白浓度与随后肿瘤形成相关, objectType=article, longId=188665, objectId=bb0918866552, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb0918866552, replyNumber=0, likeNumber=68, createdTime=2020-02-25, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb0918866552, moduleTitle=GUT：粪便免疫化学结果阴性的受试者中的粪便血红蛋白浓度与随后肿瘤形成相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb0918866552)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446104, encodeId=a3f514461045f, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=瑞德西韦（Remdesivir）治疗新冠肺炎受试者招募广告, objectType=article, longId=187825, objectId=d64718e825fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d64718e825fb, replyNumber=0, likeNumber=85, createdTime=2020-02-12, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d64718e825fb, moduleTitle=瑞德西韦（Remdesivir）治疗新冠肺炎受试者招募广告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d64718e825fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1446103, encodeId=26eb14461037b, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, objectTitle=BMC Anesthesiology：右美托咪定和丙泊酚对健康受试者体内循环细胞因子水平的影响, objectType=article, longId=186922, objectId=075418692292, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=075418692292, replyNumber=0, likeNumber=106, createdTime=2020-01-30, rootId=0, userName=xinmeili, userId=24035191312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=075418692292, moduleTitle=BMC Anesthesiology：右美托咪定和丙泊酚对健康受试者体内循环细胞因子水平的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=075418692292)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

受试者

2020-05-29

xinmeili (审核中...)

前往app查看评论内容

#受试者#

药物临床试验受试者隐私保护的有关伦理问题及其研究进展

2020-10-31

xinmeili (审核中...)

前往app查看评论内容

#受试者#

“说谎”的临床研究受试者

2020-08-08

xinmeili (审核中...)

前往app查看评论内容

#受试者#

CLIN CHEM LAB MED：中国健康受试者13个血液学参数的长期生物学变异？

2020-08-07

xinmeili (审核中...)

前往app查看评论内容

#受试者#

阿斯利康/牛津大学的COVID-19疫苗反应强烈：100%的受试者体内抗体具有中和活性

2020-07-23

xinmeili (审核中...)

前往app查看评论内容

#受试者#

NEJM：美国最早启动的新冠疫苗使受试者均产生抗体，预防效果要观后效

2020-07-18

xinmeili (审核中...)

前往app查看评论内容

#受试者#

NEJM：Moderna的COVID-19候选疫苗在所有受试者中诱导了强烈的免疫应答

2020-07-17

xinmeili (审核中...)

前往app查看评论内容

#受试者#

GUT：地中海饮食降低超重和肥胖受试者的血浆胆固醇并改善肠道微生物组成

2020-07-04

xinmeili (审核中...)

前往app查看评论内容

#受试者#

J Clin Periodontol:自我菌斑控制频率对有牙周炎病史的受试者牙龈健康的影响

2020-06-27

xinmeili (审核中...)

前往app查看评论内容

#受试者#

重磅！抗体阳转率100%！全球新冠灭活疫苗所有受试者全部产生抗体

2020-06-18

xinmeili (审核中...)

前往app查看评论内容

#受试者#

新冠肺炎治疗性抗体进入临床试验，全球首例受试者已给药完成

2020-06-11

xinmeili (审核中...)

前往app查看评论内容

#受试者#

新版GCP第三十九条解读——受试者、研究者和医疗机构的补偿和保险

2020-05-23

xinmeili (审核中...)

前往app查看评论内容

#受试者#

赛诺菲拟招募数千受试者开展新冠疫苗试验，已在多国讨论购买

2020-05-08

xinmeili (审核中...)

前往app查看评论内容

#受试者#

J Allergy Clin Immunol：天然花粉接触下过敏和不过敏受试者症状预测生物标记的确定

2020-04-24

xinmeili (审核中...)

前往app查看评论内容

#受试者#

深度：新药受试者招募的喜与忧

2020-04-14

xinmeili (审核中...)

前往app查看评论内容

#受试者#

J Dent Res：牙龈免疫细胞功能的根本性差异可能导致了T2D受试者PD的风险和严重程度的增加

2020-04-10

xinmeili (审核中...)

前往app查看评论内容

#受试者#

【研究】在研疫苗对健康受试者到底有多大风险？

2020-04-01

xinmeili (审核中...)

前往app查看评论内容

#受试者#

Front Pharmacol：常规抗骨质疏松药物治疗是否可以降低男性受试者发生骨折的风险

2020-03-06

xinmeili (审核中...)

前往app查看评论内容

#受试者#

GUT：粪便免疫化学结果阴性的受试者中的粪便血红蛋白浓度与随后肿瘤形成相关

2020-02-25

智慧医人 (审核中...)

前往app查看评论内容

#受试者#

瑞德西韦（Remdesivir）治疗新冠肺炎受试者招募广告

2020-02-12

xinmeili (审核中...)

前往app查看评论内容

#受试者#

BMC Anesthesiology：右美托咪定和丙泊酚对健康受试者体内循环细胞因子水平的影响

2020-01-30

科室
- - 订阅+
  - 更多科室
工具
服务